NCT04163757已完成不适用
The Effects of Crocin Supplementation on Metabolic Parameters, Oxidative Stress, AMP- Activated Protein Kinase and Inflammation-promoting Genes Expression in Peripheral Blood Mononuclear Cells in Patients With Type 2 Diabetes
National Nutrition and Food Technology Institute1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2019年1月20日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- type 2 diabetes
研究概览
简要总结
To study the effects of crocin supplement in patients with type 2 diabetes, 50 patients will be randomly allocated to placebo group and 2 tablets of crocin for 12 weeks. At the first and the end of the intervention, lipid profiles, blood pressure, blood sugar, inflammatory and anthropometric factors will be assessed and compared between groups.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 40 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age of 40 to 65 years type 2 diabetes: and body mass index range of 18.5 to 30 kg/m2
排除标准
- •pregnancy or lactation A history of Cardiovascular disease, Pulmonary disease, Renal disease
研究组 & 干预措施
placebo
Placebo Comparator
干预措施: placebo (Dietary Supplement)
crocin
Active Comparator
干预措施: crocin (Dietary Supplement)
结局指标
主要结局
type 2 diabetes
时间窗: 12 weeks
number of participants with normal plasma glucose
次要结局
未报告次要终点
研究者
Dr Azita Hekmatdoost
Principal Investigator
National Nutrition and Food Technology Institute
研究点 (1)
Loading locations...
相似试验
撤回
1 期
A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection TherapyDiabetes Mellitus, Type 2NCT02623465Eli Lilly and Company
已完成
1 期
A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection TherapyDiabetes Mellitus, Type 2NCT02703337Eli Lilly and Company30
Unknown
1 期
KurCoSmart Effects on People With Type 2 DMInflammationDiabetes Mellitus, Type 2Body WeightInsulin ResistanceNCT05407467Universitas Sebelas Maret40
已完成
1 期
A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Insulin Icodec in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2NCT04582435Novo Nordisk A/S46
已完成
不适用
β-hydroxybutyrate, Glucose Metabolism and PrediabetesPreDiabetesNCT03889210University of Auckland, New Zealand18